Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease
Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether extracorporeal photoimmune therapy with
UVADEX (ECP) added to standard therapy is effective in the treatment of chronic
graft-versus-host disease (GvHD).